The Accuracy and Reliability of Sleep Staging and Sleep Biomarkers in Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder.

"Disclosure As shareholders in Advanced Brain Monitoring, Inc. Mr. Levendowski would financially benefit if the SP intellectual property was acquired by a third party. Mr. Levendowski has the following SP patents issued to Advanced Brain Monitoring: US 8,355,769 and 8,639,313 and EP2408353A4. Mr. Levendowski reports grants from National institute of Aging, during the conduct of the study. Dr. Lee-Iannotti serves as a paid advisor to and speaker for Jazz Pharmaceuticals. Dr Shprecher received research support from the Arizona Alzheimer’s Consortium, Abbvie, Acadia, Aptinyx, Axovant, Biogen, Cognition Therapeutics, Eisai, Eli Lilly, Enterin, Neurocrine, Michael J Fox Foundation, NIH, Nuvelution, Roche and Teva; consultant fees from Amneal, Forensis, Emalax, US World Meds/Supernus and Neurocrine; speaker honoraria from Acorda, Amneal, Intermountain Healthcare, Neurocrine, Sunovion, Teva and US World Meds. Dr. Mazeika serves as the Medical Director of Advanced Brain Monitoring, Inc. Dr. Boeve receives honoraria for SAB activities for the Tau Consortium; research support from Alector, Biogen, Transposon and GE Healthcare; research support from the NIH, the Lewy Body Dementia Association, the American Brain Foundation, the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program, the Little Family Foundation, and the Ted Turner and Family Functional Genomics Program; grants from Alector, grants from Biogen, grants from Transposon, grants from EIP Pharma, outside the submitted work. None of the other authors reported financial conflicts."

"Mr. Levendowski was supported by the National Institute of Aging (NIA)-National Institute of Health (NIH) (R44AG050326 and R44AG054256). Dr. Neylan and Dr. Walsh were supported by NIH grant RO1 AG060477 and the Rainwater Charitable Foundation. Dr. Shprecher received support from the Arizona Alzheimer’s Consortium. Dr. Boeve receives research support from the NIH (AG062677, NS100620, AG056639), the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program, the Little Family Foundation, and the Turner Family Foundation. Dr. St. Louis received research support from the NIH, National Center for Research Resources and the National Center for Advancing Translational Sciences grant UL1 RR024150-01, and by NIH/NIA R34AG056639 (NAPS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH."